The group is recognized for exceptional leadership in developing a suite of international standards as well as implementation of open-source software tools for the characterization of cell therapy products. This effort serves to anchor the development and manufacturing of game-changing living drugs by providing accessible analytical methods to help ensure product safety and efficacy, thereby supporting a growing therapeutics industry that has revolutionized treatment of previously uncurable diseases and other existing and emerging biotechnology applications.